Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PGNX > SEC Filings for PGNX > Form 8-K on 25-Jun-2013All Recent SEC Filings

Show all filings for PROGENICS PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro



Other Events

Item 8.01 Other Events.

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) today completed its previously-announced underwritten public offering of 8,500,000 primary shares of common stock at a public offering price of $4.40 per share. Net proceeds to Progenics were approximately $34.8 million, after deducting underwriting discounts and commissions and estimated offering expenses. In the offering, Jefferies LLC acted as sole book-running manager and as representative of several underwriters named in the Underwriting Agreement entered into with the Company on June 20, 2013. The offering utilized a portion of the Company's $100 million shelf registration statement, including a June 20, 2013 prospectus supplement.

  Add PGNX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PGNX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.